Lifevantage (NASDAQ:LFVN) Stock Crosses Above 200-Day Moving Average – Here’s What Happened

Lifevantage Corporation (NASDAQ:LFVN) shares passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $5.73 and traded as high as $6.84. Lifevantage shares last traded at $6.8280, with a volume of 68,409 shares.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on LFVN. Weiss Ratings upgraded Lifevantage from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, May 26th. Lake Street Capital lowered shares of Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 target price for the company. in a report on Thursday, May 7th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $5.00.

Lifevantage Stock Down 1.2%

The stock’s 50 day moving average price is $6.97 and its 200-day moving average price is $5.73. The stock has a market capitalization of $83.04 million, a PE ratio of 14.62 and a beta of 0.72.

Lifevantage (NASDAQ:LFVN) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.04). Lifevantage had a net margin of 2.94% and a return on equity of 23.89%. The business had revenue of $43.72 million for the quarter, compared to the consensus estimate of $47.77 million. As a group, sell-side analysts predict that Lifevantage Corporation will post 0.6 earnings per share for the current fiscal year.

Institutional Trading of Lifevantage

Institutional investors and hedge funds have recently made changes to their positions in the business. Capital Management Corp VA lifted its stake in shares of Lifevantage by 3.4% in the fourth quarter. Capital Management Corp VA now owns 2,134,574 shares of the company’s stock worth $13,149,000 after buying an additional 70,398 shares in the last quarter. Renaissance Technologies LLC increased its holdings in shares of Lifevantage by 8.3% during the 4th quarter. Renaissance Technologies LLC now owns 922,918 shares of the company’s stock worth $5,685,000 after buying an additional 70,900 shares during the last quarter. Wasatch Advisors LP grew its position in Lifevantage by 6.6% in the second quarter. Wasatch Advisors LP now owns 446,341 shares of the company’s stock worth $5,838,000 after acquiring an additional 27,765 shares during the period. Geode Capital Management LLC raised its position in Lifevantage by 106.1% in the second quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock valued at $3,210,000 after purchasing an additional 126,274 shares during the period. Finally, Goldman Sachs Group Inc. lifted its position in Lifevantage by 305.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 200,222 shares of the company’s stock valued at $1,233,000 after buying an additional 150,785 shares during the last quarter. 35.32% of the stock is currently owned by hedge funds and other institutional investors.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.